Back to today’s briefing

Story perspectives

FDA Reports Surge in Drug-Induced Photosensitivity Cases

5/24/2025

41 6

Summary

Story summary

Between 2004 and 2023, the FDA documented over 20,000 instances of drug-induced photosensitivity, predominantly tied to immunosuppressants and monoclonal antibodies. Pirfenidone topped the list of culprits, with the majority of cases emerging from the USA. Alarmingly, there’s been a rise in reports linked to drugs like lamotrigine and vemurafenib, highlighting a growing concern.

1 of 1

Story summary

Between 2004 and 2023, the FDA documented over 20,000 instances of drug-induced photosensitivity, predominantly tied to immunosuppressants and monoclonal antibodies. Pirfenidone topped the list of culprits, with the majority of cases emerging from the USA. Alarmingly, there’s been a rise in reports linked to drugs like lamotrigine and vemurafenib, highlighting a growing concern.